Crossmark

Hyperprogressive disease induced by PD-1 inhibitor monotherapy in lung adenocarcinoma with HER2 exon 20 insertion: report of two cases and review of literature

Crossref DOI link: https://doi.org/10.1007/s12672-025-01749-3

Published Online: 2025-01-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Guangjian

Tian, Linyan

Wang, Yan
License Information

Text and Data Mining valid from 2025-01-06

Version of Record valid from 2025-01-06
More Information

Article History

Received: 9 September 2024

Accepted: 2 January 2025

First Online: 6 January 2025

Declarations

:

: This study was granted an exemption from requiring ethics approval from the Ethics Committee of National Cancer Center/Cancer Hospital, as it was an observational report. All the human data was in accordance with the guidelines of the 1964 Declaration of Helsinki, and written informed consent for study participation from these two patients was obtained.

: Written informed consent was obtained from these two patients for the publication of their case report and any accompanying images.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below